Pages that link to "Q34398555"

The following pages link to Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine (Q34398555):

Displaying 12 items.

• Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects (Q24541281) (← links)
• Drug treatment of epilepsy in elderly people: focus on valproic Acid (Q28194670) (← links)
• Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience (Q33961525) (← links)
• Antiepileptic drug treatment: outcomes and adherence (Q33999491) (← links)
• Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics (Q36857493) (← links)
• The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter (Q37237076) (← links)
• Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children (Q39074126) (← links)
• Therapeutic drug monitoring in pediatrics: a need for improvement (Q40666608) (← links)
• Antiepileptic drugs. A review of clinically significant drug interactions. (Q40780187) (← links)
• Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations (Q41271354) (← links)
• Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation (Q43190362) (← links)
• Effect of valproic acid on the pharmacokinetic profile of oxcarbazepine in the rat (Q74621651) (← links)